NEWS|

July, 2014
     HBV Rebounds After Stopping
     Entecavir ... more

July, 2014
     PharmaEssentia upbeat on trials in
     Europe for bone ... more

April, 2014
     Europe a promising market
     for new drug ... more

March, 2014
     PharmaEssentia is listed on
     emerging stock market ... more

Company Profile
PharmaEssentia Corporation is a global pharmaceutical company founded by a group… more
What is MPD
Meloproliferative diseases (MPD) includes chronic myeloid leukemia (CML)… more
PEGylation
In the field of protein drug design, the process of so-called 'PEGylaltion' of the therapeutic protein… more


Copyright © 2008 PharmaEssentia Corporation All Rights Reserved.